Utah Survey Reveals Cost Barriers in Medical Cannabis Program

A new survey from the Utah Department of Agriculture & Food shows enrollment costs remain the biggest hurdle for patients trying to access the state's medical cannabis program, with more than a quarter of respondents identifying fees as a barrier to participation.

The department surveyed 14,600 participants and potential participants in Utah's medical marijuana program, drawing responses from 7,222 active cardholders, 2,770 individuals with expired cards, and 959 cannabis consumers who've never enrolled. Among all respondents, 27% described enrollment costs as preventing or limiting their access to the program.

Utah's medical cannabis program requires patients to pay $15 for a medical card application, though the state offers a reduced $5 fee for veterans, individuals on Supplemental Security Income, and those enrolled in Medicare or Medicaid. Patients must also cover the cost of a physician consultation to obtain a recommendation—a fee that varies widely depending on the provider but typically ranges from $150 to $300.

The Financial Calculus

The survey results underscore a tension playing out across state medical cannabis programs nationwide. Utah implemented its medical marijuana system in 2020 following voter approval of Proposition 2 in 2018, but the program has faced criticism over accessibility issues since its inception.

For patients with expired cards—nearly 3,000 of whom participated in the survey—the decision to renew often comes down to economics. The annual renewal process requires both the state fee and another physician visit, creating recurring costs that some patients struggle to justify, particularly if they're managing their conditions through other means or turning to the illicit market.

Utah's program currently serves around 38,000 active patients, a relatively modest number for a state of 3.4 million residents. By comparison, neighboring Colorado's medical program—operating since 2000—maintains roughly 78,000 active patients despite the state's adult-use market offering an alternative pathway to access.

What Patients Are Saying

The UDAF survey represents one of the most comprehensive assessments of Utah's medical cannabis program to date. Beyond cost concerns, respondents also flagged issues with product availability, dispensary locations, and qualifying condition restrictions—though cost emerged as the dominant theme.

The inclusion of nearly 1,000 cannabis consumers who've never enrolled in the program offers particularly revealing data. These respondents—who by definition are accessing cannabis through illegal channels—cited enrollment costs as a primary reason for remaining outside the regulated system.

Reform Prospects

Utah lawmakers have periodically revisited the state's medical cannabis framework since its implementation. The 2024 legislative session saw multiple bills aimed at expanding qualifying conditions and improving program access, though none directly addressed enrollment fee structures.

Some patient advocates argue the state should eliminate enrollment fees entirely, pointing to the program's original intent to provide medical relief for qualified patients. Others suggest a tiered fee structure could better accommodate patients across different income levels while maintaining program funding.

The UDAF survey arrives as Utah officials prepare for the 2025 legislative session, where medical cannabis policy could again take center stage. With concrete data now showing cost as a measurable barrier, legislators face renewed pressure to address program accessibility—particularly as the state works to shift consumers from the illicit market to regulated channels.

The department has not yet announced specific recommendations based on the survey findings, though officials indicated the data would inform future policy discussions and program improvements.

---

This article is based on original reporting by ganjapreneur.com.